Healthcare-focused venture capital firm NeoMed Management has launched a vehicle specifically dedicated to brain tumour therapy development.
Catch up on essential features from this past week with our round-up of industry analysis
Director Théodore Schneider will reinvest alongside CVC to retain a 20% stake in the company
Sale follows a three-year tenure and reportedly values the care home operator at €236m
Following a three-year holding period, the GP sells its stake to a consortium led by Hat Orizzonte